共 50 条
- [2] Bioequivalence study of dacomitinib and Vizimpro® in healthy Chinese volunteers under fasting and fed conditions: A randomized, open-label, single-dose, crossover trial [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (12): : 2591 - 2603
- [5] Study on the bioequivalence of two formulations of eplerenone in healthy volunteers under fasting conditions: data from a single-center, randomized, single-dose, open-label, 2-way crossover bioequivalence study [J]. ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2011, 61 (03): : 153 - 159
- [6] Comparative Randomized, Single-Dose, Two-Way Crossover Open-Label Study to Determine the Bioequivalence of Two Formulations of Dalfampridine Tablets [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (03): : 355 - 360
- [7] Pharmacokinetic and Safety Comparison of 2 Afatinib Dimaleate Tablets in Healthy Chinese Volunteers Under Fasted Conditions: A Randomized, Open-Label, 2-Period, Single-Dose Crossover Study [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (10): : 1177 - 1183
- [9] Pharmacokinetics and Bioequivalence of Misoprostol Tablets: An Open-Label, Randomized, Single-dose, Crossover Study With Healthy Chinese Volunteers [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (08): : 949 - 956